Cas 1022170-91-7,N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea

1022170-91-7

Post Buying Request

Basic information

Product Name: N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea
Synonyms: N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea
CAS NO:1022170-91-7
Molecular Formula:
Molecular Weight: 478.702
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea(1022170-91-7)
EPA Substance Registry System: N-(4-{2-[5-(3,5-di-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]ethyl}phenyl)-N'-propylurea(1022170-91-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1022170-91-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1022170-91-7 Suppliers

Recommended suppliers

1022170-91-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1022170-91-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,2,1,7 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1022170-91:
(9*1)+(8*0)+(7*2)+(6*2)+(5*1)+(4*7)+(3*0)+(2*9)+(1*1)=87
87 % 10 = 7
So 1022170-91-7 is a valid CAS Registry Number.

1022170-91-7Upstream product

1022170-91-7Downstream Products

1022170-91-7Relevant academic research and scientific papers

PHENYL DERIVATIVES AND THEIR USE AS A MEDICAMENT

-

Page/Page column 21, (2010/04/23)

The present invention relates to new phenylic derivatives exhibiting a good affinity for certain sub-types of cannabinoid receptors, in particular the CB2 receptors. These derivatives are of particular interest in a method for treating pathological conditions and diseases in which one or more cannabinoid receptors are involved. The invention also relates to pharmaceutical compositions containing said new phenylic derivatives and to methods for the preparation and use thereof.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1022170-91-7